What Medication Is Used to Prevent RSV in High-Risk Infants?

Learn about Palivizumab, the medication used to prevent severe RSV infections in high-risk infants and young children through targeted injections.

0 views

Palivizumab is a medication used as a preventive measure against severe respiratory syncytial virus (RSV) infections. Mainly recommended for high-risk infants and young children, it is administered through injections. Its usage is typically guided by specific eligibility criteria, emphasizing its role in protecting vulnerable populations from RSV complications.

FAQs & Answers

  1. What is Palivizumab and how does it work? Palivizumab is a monoclonal antibody medication given via injections to prevent severe respiratory syncytial virus (RSV) infections, especially in high-risk infants and young children.
  2. Who should receive medication to prevent RSV? Medication like Palivizumab is recommended mainly for high-risk infants and young children, including those born prematurely or with certain heart and lung conditions.
  3. Is Palivizumab a treatment or preventive medication? Palivizumab is used as a preventive measure and is not a treatment for active RSV infection; it helps reduce the risk of severe RSV complications.